Brian Turpin

Efficacy of Larotrectinib in <i>TRK</i> Fusion–Positive Cancers in Adults and Children

Alexander Drilon, Theodore W. Laetsch, Shivaani Kummar et al. · New England Journal of Medicine · 2018 · 2.7K citations · Full text

Medicine, Oncology, Pharmacology +16

Larotrectinib for paediatric solid tumours harbouring NTRK gene fusions: phase 1 results from a multicentre, open-label, phase 1/2 study

Theodore W. Laetsch, Steven G. DuBois, Leo Mascarenhas et al. · The Lancet Oncology · 2018 · 552 citations · Full text

Medicine, Molecular Biology, Oncology +16

Severe cytokine release syndrome in a patient receiving PD‐1‐directed therapy

Seth J. Rotz, Daniel Leino, Sara Szabo et al. · Pediatric Blood & Cancer · 2017 · 157 citations

Life Sciences, Immunology, Oncology +17

Expanding the Spectrum of Pediatric NTRK-rearranged Mesenchymal Tumors

Jessica L. Davis, Christina M. Lockwood, Bradley A. Stohr et al. · The American Journal of Surgical Pathology · 2018 · 138 citations

Medicine, Oncology, Pathology +17

The use of neoadjuvant larotrectinib in the management of children with locally advanced TRK fusion sarcomas

Steven G. DuBois, Theodore W. Laetsch, Noah Federman et al. · Cancer · 2018 · 136 citations · Full text

Medicine, Oncology, Surgery +17